185,077 Shares in Cabot Corporation $CBT Purchased by William Blair Investment Management LLC

Key Points

• William Blair Investment Management purchased 185,077 Cabot shares worth approximately $16.8 million, while institutional investors and hedge funds collectively own 93.18% of the company.
• Cabot exceeded quarterly expectations with $1.67 in EPS and $982 million in revenue, up 6.4% year over year. The company issued fiscal 2026 EPS guidance of $6.15–$6.45.
• Cabot declared a quarterly dividend of $0.4725 per share, equivalent to $1.89 annually and a 2.2% yield. Analysts maintain a consensus “Hold” rating with an average price target of $89.

William Blair Investment Management LLC bought a new stake in shares of Cabot Corporation (NYSE:CBT - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 185,077 shares of the specialty chemicals company's stock, valued at approximately $16,809,000. William Blair Investment Management LLC owned approximately 0.36% of Cabot at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Allworth Financial LP purchased a new stake in shares of Cabot in the second quarter valued at approximately $145,000. Advisors Capital Management LLC acquired a new position in shares of Cabot during the 2nd quarter worth approximately $267,000. PCM Encore LLC purchased a new position in shares of Cabot during the 2nd quarter valued at approximately $519,000. Vise Technologies Inc. purchased a new position in shares of Cabot during the 2nd quarter valued at approximately $205,000. Finally, Foster & Motley Inc. acquired a new stake in Cabot in the 2nd quarter valued at $1,194,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Stock Up 0.2%

Shares of NYSE CBT opened at $85.10 on Friday. The stock has a market cap of $4.39 billion, a PE ratio of 23.97, a P/E/G ratio of 11.11 and a beta of 0.84. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $94.53. The company has a 50-day moving average of $88.18 and a 200 day moving average of $80.87.

Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. The business had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business's revenue was up 6.4% on a year-over-year basis. During the same period last year, the company posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, sell-side analysts predict that Cabot Corporation will post 6.33 EPS for the current fiscal year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. Cabot's payout ratio is 53.24%.

Wall Street Analyst Weigh In

CBT has been the subject of a number of research reports. UBS Group cut their target price on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research note on Wednesday, August 5th. Weiss Ratings reiterated a "hold (c)" rating on shares of Cabot in a report on Tuesday, May 26th. Mizuho boosted their price objective on Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a research note on Thursday, June 25th. Truist Financial set a $100.00 target price on Cabot in a report on Wednesday, August 5th. Finally, Wall Street Zen upgraded Cabot from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Cabot currently has a consensus rating of "Hold" and an average target price of $89.00.

Insiders Place Their Bets

In other Cabot news, CEO Sean D. Keohane sold 91,923 shares of the company's stock in a transaction on Friday, August 7th. The stock was sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at $34,921,218.94. This represents a 18.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 3.08% of the company's stock.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.